Anti-oxidative trypanocidal drugs, myth or reality by Soodabeh Saeidnia
Saeidnia DARU Journal of Pharmaceutical Sciences 2013, 21:21
http://www.darujps.com/content/21/1/21LETTER TO THE EDITOR Open AccessAnti-oxidative trypanocidal drugs, myth or reality
Soodabeh SaeidniaSir,
“Blueberries best be eaten because they taste good, not
because their consumption will lead to less cancer.” Prof.
Jim Watson [1].
Recently, Professor Jim Watson, father of DNA
double-helix, has described in his paper that antioxidant
supplements may have caused more cancers than they
have prevented. Alongside this controversial, several pa-
pers give rise on looking for anti-cancers among antioxi-
dants [2-4]. In reality, mechanism of anti-cancer action
is very important, where induction of free radicals and
augmentation of Reactive Oxygen Species (ROS) are the
main pharmacological modes of anti-neoplastic activity
[5]. In spite of the fact that beneficial role of antioxidants
in chemoprevention of cancer has been well-known, ef-
fectiveness of them in treatment of cancer is still in
challenge.
Interestingly, there is a similar situation for another
important disease, Chagas (American trypanosomiasis),
a tropical parasitic illness caused by the flagellate proto-
zoan Trypanosoma cruzi and affects eight to 10 million
people residing in Latin American countries [6,7]. Now-
adays natural compounds have been evaluated for dis-
covery of new chemotherapeutics in treatment of
Chagas disease. But, literature revealed that most of the
researchers select the compounds without attention to
their probable antioxidant activity, while therapeutic ac-
tion of the remarkable trypanocidal compounds like
elatol involves mitochondria as the primary target lead-
ing to increase of ROS generation through the electron
transport chain, which consequently affects cell mem-
brane and DNA integrity and finally death of parasite
[8]. Although this is not the only mechanism of action
for trypanocidal drugs, well-known natural phenolics
such as gallic acid can act via pro-oxidant activity as
well as enhancing DNA single-strand breaks to kill
Trypanosoma [9]. Furthermore, anti-trypanosoma activ-
ity of komaroviquinone (a diterpenoid) was found to be
attributed by generation of ROS catalyzed by T. cruziCorrespondence: saeidnia_s@tums.ac.ir
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reproduction in any medium, provided the orold yellow enzyme [10]. It seems that potent natural an-
tioxidants like hydroxycoumarins derivatives or flavo-
noids are not potentially strong trypanocidal agents [11].
The question arise from this concept is “why does a
physician recommend consumption of antioxidant in
treatment of trypanosomiasis?” The answer to this ques-
tion may be hidden behind the differences in mechanism
of actions for trypanocidal drugs and also the role of an-
tioxidants in prevention of inflammation in this illness.
To the best of our knowledge, consumption of antioxi-
dant supplements is new perspective in therapy of
Chagas disease because of the attenuation of oxidative
stress associated to this disease [12]. Additionally, it has
been reported that Trypanosoma infection decreases the
levels of reduced glutathione (GSH) in the blood, liver,
kidney, and also the plasma levels of vitamin C [13]. For
this reason, they believe that supplementation of
infected patient with vitamin C could prevent the deple-
tion of endogenous antioxidants. Actually, another prob-
able reason for this entrenched attitude is the ubiquitous
application of antioxidant supplements. Therefore, we
recommend the researchers to focus on possible mode
of actions for trypanocidal candidates, especially when
the nominated compounds are proved to possess anti-
oxidant ability.
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